These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9884181)

  • 1. Progress in complementary and alternative medicine: contribution of the National Institutes of Health and the Food and Drug Administration.
    Eskinazi D; Hoffman FA
    J Altern Complement Med; 1998; 4(4):459-67. PubMed ID: 9884181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Institutes of Health Office of Alternative Medicine-Food and Drug Administration Workshop on Acupuncture.
    Eskinazi DP; Jobst KA
    J Altern Complement Med; 1996; 2(1):3-6. PubMed ID: 9395635
    [No Abstract]   [Full Text] [Related]  

  • 3. Complementary and alternative therapeutics: rigorous research is needed to support claims.
    Kinsel JF; Straus SE
    Annu Rev Pharmacol Toxicol; 2003; 43():463-84. PubMed ID: 12540748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of traditional Chinese medicine in United States].
    Tian XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):715-9. PubMed ID: 23073580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
    Kantor M
    J Am Coll Radiol; 2009 Apr; 6(4):254-62. PubMed ID: 19327658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.
    White JD
    J Altern Complement Med; 2002 Oct; 8(5):545-50. PubMed ID: 12470434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CAM Education Program of the National Center for Complementary and Alternative Medicine: an overview.
    Pearson NJ; Chesney MA
    Acad Med; 2007 Oct; 82(10):921-6. PubMed ID: 17895649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation.
    Cohen MH
    Dermatol Ther; 2003; 16(2):77-84. PubMed ID: 12919107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating complementary and alternative medicine instruction into health professions education: organizational and instructional strategies.
    Lee MY; Benn R; Wimsatt L; Cornman J; Hedgecock J; Gerik S; Zeller J; Kreitzer MJ; Allweiss P; Finklestein C; Haramati A
    Acad Med; 2007 Oct; 82(10):939-45. PubMed ID: 17895652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medicine research: a National Cancer Institute perspective.
    White JD
    Semin Oncol; 2002 Dec; 29(6):546-51. PubMed ID: 12516037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in complementary and alternative medicine research: Yale Research Symposium on Complementary and Integrative Medicine.
    Millet JD
    Yale J Biol Med; 2010 Sep; 83(3):127-9. PubMed ID: 20885899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New opportunities and proven approaches in complementary and alternative medicine research at the National Institutes of Health.
    Harlan WR
    J Altern Complement Med; 2001; 7 Suppl 1():S53-9. PubMed ID: 11822636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop.
    Lin MC; Nahin R; Gershwin ME; Longhurst JC; Wu KK
    Circulation; 2001 Apr; 103(16):2038-41. PubMed ID: 11319191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Center for Complementary and Alternative Medicine perspectives for complementary and alternative medicine research in cardiovascular diseases.
    Wong SS; Nahin RL
    Cardiol Rev; 2003; 11(2):94-8. PubMed ID: 12620133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and Alternative Medicine (CAM): considerations for the treatment of major depressive disorder.
    Freeman MP
    J Clin Psychiatry; 2009; 70 Suppl 5():4-6. PubMed ID: 19909686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborations between allopathic and complementary and alternative medicine health professionals: four initiatives.
    Nedrow AR; Heitkemper M; Frenkel M; Mann D; Wayne P; Hughes E
    Acad Med; 2007 Oct; 82(10):962-6. PubMed ID: 17895657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIH Office of Alternative Medicine Conference: federal agencies explore the potential role of botanicals in U.S. health care.
    Hoffman FA; Eskinazi D
    J Altern Complement Med; 1995; 1(3):303-8. PubMed ID: 9395625
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical practice guidelines in complementary and alternative medicine. An analysis of opportunities and obstacles. Practice and Policy Guidelines Panel, National Institutes of Health Office of Alternative Medicine.
    Arch Fam Med; 1997; 6(2):149-54. PubMed ID: 9075450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.